Evidence map›Paper›PMID 42720895›Full record

ArticleApplied biochemistry and biotechnology2026

An Ultrasensitive Fluorescent Immunoassay Based on R-CDs@SiO

Li Wang, Lei Li, Wei Chen, Mingcui Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in Applied biochemistry and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Li WangThe Key Laboratory of Functional Molecular Solids, Ministry of Education, Anhui Key Laboratory of Biomedical Materials and Chemical Measurement, College of Chemistry and Molecular Sciences, Anhui Normal University, Wuhu, 241002, P. R. China.
Lei LiCentral Laboratory, Yijishan Hospital, The First Affiliated Hospital of Wannan Medical University, Wuhu, 241001, P. R. China.
Wei ChenThe Key Laboratory of Functional Molecular Solids, Ministry of Education, Anhui Key Laboratory of Biomedical Materials and Chemical Measurement, College of Chemistry and Molecular Sciences, Anhui Normal University, Wuhu, 241002, P. R. China.
Mingcui ZhangThe Key Laboratory of Functional Molecular Solids, Ministry of Education, Anhui Key Laboratory of Biomedical Materials and Chemical Measurement, College of Chemistry and Molecular Sciences, Anhui Normal University, Wuhu, 241002, P. R. China. zhangmc@mail.ahnu.edu.cn.ORCID http://orcid.org/0000-0001-8087-766X

Funding

Anhui provincial Natural Science Foundation 2108085MB68National Natural Science Foundation of China 21175004the University Synergy Innovation Program of Anhui Province GXXT-2020-074
6 · The paper itself

Abstract

Highly sensitive detection of cardiac troponin I (cTnI) is of great significance for the early diagnosis and prognosis assessment of acute myocardial infarction (AMI). Conventional single carbon dot fluorescent probes are inherently limited by weak fluorescence intensity, challenging biofunctionalization and unsatisfactory detection sensitivity. Herein, we report an immunoassay strategy based on red-emissive silica-encapsulated carbon dots (R-CDs@SiO

Indexed as

BiosensorCardiac troponin IFluorescence immunoassayH9C2 cellsRed carbon dotsSilicon dioxide

Identifiers

PMID42720895

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.